Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
bacterial infection
cerebrovascular accident
cerebrovascular accident, mimics
chlorpropamide
coma
diabetes mellitus
drug induced neurologic disorders
genetic neurologic disorders
hemiparesis
hypoglycemia
hypoglycemic agent, oral
hypoglycemic coma
iatrogenic neurologic disorders
insulin
level of consciousness, decreased
mimics
mortality
old age, neurology of
optic neuropathy
optic neuropathy, toxic
seizure
tolazamide
transketolase
visual loss
Wernicke's encephalopathy
Showing articles 200 to 250 of 4607 << Previous Next >>

Radiation-Induced Carotid Artery Stenosis in Patients with Head and Neck Cancer: A Comprehensive Review of Imaging Features, Pathogenesis, and Clinical Manifestations
AJNR 47:2478-2485, Wiepert,L.M.,et al, 2026

Brexpiprazole-Induced Tardive Dystonia
Neurol 107:e218603, Anekwe,J.,et al, 2026

Safety of Antiseizure Medications During Direct Oral Anticoagulant Therapy in Epilepsy
JAMA Neurol 83:1002-1012, Schubert,K.M.,et al, 2026

GLP-1s:Novo Nordisk and Eli Lilly Face Laswsuit Over Vision Loss andw Eye Damage
BMJ 395:e101099, Cozzolino,A., 2026

Tenecteplase for Acute Non-Large Vessel Occlusion 4.5 to 24 Hours After IschemicStroke, The OPTION Randomized Clinical Trial
JAMA doi:10.1001/JAMA.2026.0210, Ma,G.,et al, 2026

Timing and Safety of Anticoagulation Reinitiation After Intracranial Hemorrhage in Patients with Mechanical Valves
Neurol 105:e214184, DAnna,L.,et al, 2025

Effectiveness and Safety of IV Thrombolysis Before Hospital Transfer for Thrombectomy in Patients With Basilar Artery Occlusion
Neurol 105:e214355, Liebart,S.,et al, 2025

Anticoagulant Usage and Risk of Thromboembolic Events After Ischemic Stroke in Adults with Cancer
Neurol 105:e214325, Balali,P.,et al, 2025

Upbeat Nystagmus From Dorsolateral Pontine Hemorrhagic Transformation
Neurol 106:e214467, Chen,H. & Li, J., 2025

Chasing the New Dragon, Toxic Spongiform Leukoencephalopathy with Chronic Fentanyl Inhalation
Neurol 106:e214517, Maisenbacher,M. & Jayagopal, L.A., 2025

The Multifactorial Nature of Ischemic Stroke in Malignancy
Stroke 56:e303-e306, Doyle,C.L.,et al, 2025

Clinicopathologic Features, Pathogenesis, and Treatment of Monoclonal Gammopathy-Associated Myopathies
Neurol 105:213101, Soontrapa,P.,et al, 2025

Early Thrombolysis and Outcomes in Central Retinal Artery Occlusion:An Individual Participant Data Meta-Analysis
Stroke 56:3175-3186, Xie,J.S.,et al, 2025

Effectiveness of Endovascular Treatment for Acute Mild Basilar Artery Occlusion Stroke:A Multicenter Real-World Study
Stroke 56:3187-3198, Xiao,Y.,et al, 2025

Clinicopathologic Conference, Chagas Disease
NEJM 393:1216-1225, Case 27-2025, 2025

New Treatments for Migraine: CGRP Monoclonal Antibodies, Gepants, and Ditans
BMJ 390:e085564, Burch, R. & Rittenberg, E., 2025

Neuroimaging Findings in Children and Young Adults with Neurotoxicity after CAR T-Cell Therapy for B-Cell Malignancies
Neurol 105:e214086, McGuire,J.L.,et al, 2025

Idiopathic Intracranial Hypertension
NEJM 393:1409-1414, Horton,J.C., 2025

Endovascular Thrombectomy for Extracranial Internal Carotid Artery Occlusions with Large Ischemic Strokes
Neurol 104:e210269, Ortega-Gutierrez,S.,et al, 2025

Endovascular Therapy for Patients with Low NIHSS Scores and Large Vessel Occlusion in the 6- to 24-Hour Window
Neurol 104:e213442, Marto,J.P.,et al, 2025

Inebilizumab for Treatment of IgG4-Related Disease
NEJM 392:1168-1177, Stone,J.H.,et al, 2025

Beyond Glucocorticoids for IgG4-Related Disease
NEJM 392:1232-1233, Spiera,R., 2025

Alteplase for Posterior Circulation Ischemic Stropke at 4.5 to 24 Hours
NEJM 392:1288-1296, Yan,S.,et al, 2025

Left Atrial Appendage Closure After Ablation for Atrial Fibrillation
NEJM 392:1277-1287, Wazni,O.M.,et al, 2025

"Innumerable" lesion burden on brain MRI - a diagnostic approach
Diagnosis doi.org/10.1515/dx- 2025-2029, Finelli,P.F., 2025

Endovascular Treatment of Stroke Due to Medium-Vessel Occlusion
NEJM 392:1385-1395,1440, Goyal,lM.,et al, 2025

Endovascular Treatment for Stroke Due to Occlusion of Medium or Distal Vessels
NEJM 392:1374-1384,1440, Psychogios,M.,et al, 2025

Chronic Neuropsychiatric Sequelae Associated with Kambo Intoxication
JAMA Neurol 82:418-419, Jauregui,R.,et al, 2025

Endovascular Thrombectomy for Large Ischemic Core Stroke, A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Neurol 104:e213443, Liu,C.,et al, 2025

Anticoagulation or Antiplatelet Therapy for Device-Detected Atrial Fibrillation
NEJM 392:1749-1751, Gorey,S., 2025

A 69-Year-Old Woman with Ophthalmoplegia
Neurol 104:e213763, Yu, H & Frey, J, 2025

Risk of Dementia in Individuals with Emergency Department Visits or Hospitalizations Due to Cannabis
JAMA Neurol 82:570-579, Myran,D.T.,et al, 2025

Aspirin Continuation or Discontinuation in Surgically Treated Chronic Subdural Hematoma, A Randomized Clinical Trial
JAMA Neurol 82:551-559, Kamenova,M.,et al, 2025

A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
NEJM 392:2309-2320, Nowak,R.J.,et al, 2025

Myasthenia Gravis - Redemption for B-Cell Depletion
NEJM 392:2382-2384, Wolfe,G.I. & Shelly,S., 2025

Efficacy and Safety of Ofatumumab Treatment for Anti-NMDA Receptor Autoimmune Encephalitis (OFF-AE): A Prospective, Multicenter Cohort Study
Ann Neurol 98:80-92, Guo,K.,et al, 2025

Intravenous Tenecteplase before Thrombectomy in Stroke
NEJM 393:139-150, Qiu,Z.,et al, 2025

Left Atrial Appendage Occlusion and Its Role in Stroke Prevention
Stroke 56:1928-1937, Seiffge,D.J.,et al, 2025

Intra-Arterial Thrombolysis Following Endovascular Recanalization for Large Vessel Occlusion Stroke
Neurol 105: e213842, Jiang,X.,et al, 2025

Clinicopathological Conference, Powasan Virus Encephalitis
NEJM 393:176-184, Case 19-2025, 2025

Routine Cerebral Embolic Protection during Transcatheter Aortic-Valve Implantation
NEJM 392:2403-2412, 2473, Kharbanda,R.K.,et al, 2025

Collaboration on the Optimal Timing of Anticoagulation after Ischaemic Stroke and Atrial Fibrillation:A Systematic Review and Prospective Individual Participant Data Meta-Analysis of Randomised Controlled Trials (CATALYST)
Lancet 406:43-51, Dehbi,K-M.,et al, 2025

Outcomes of Patients with Embolic Stroke of Undetermined Source Treated with Antiplatelet Agents or Anticoagulation, A Multicenter Cohort Study
Neurol 105: e213876, Seigler,J.E.,et al, 2025

Real-World Evidence of Brexpiprazole Use and 6-Month Mortality, Hospitalization, and Emergency Department Visits Among Persons with Dementia
Neurol 105: e213717, Zissimopoulos, J.,et al, 2025

Residual Risk of Recurrent Stroke Despite Anticoagulation in Patients with Atrial Fibrillation,A Systematic Review and Meta-Analysis
JAMA Neurol 82:696-705, McCabe,J.J.,et al, 2025

Frequency, Risk Factors, and Outcomes of Strokes in Patients with Primary Glioma After Cranial Radiation
Neurol 105:e213902, Ryan,D.,et al, 2025

Spectrum of Intracranial Hemorrhages in Cerebral Venous Thrombosis, A Pictorial Case Series and Review of Pathophysiology and Management
Neurologist 30:45-51, Jha,S.,et al, 2025

Efficacy and Safety of IV Thrombolysis for Acute Ischemic Stroke Patients with Moyamoya Disease
Neurol 104:e210243, Chen,H.,et al, 2025

Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease
JAMA Neurol 92:19-29, Salloway,S.,et al, 2025

Clinicopathologic Conference, Posterior Reversible Encephalopathy Syndrome Due to Sickle Cell Disease
NEJM 392:268-276, Case 2-2025, 2025



Showing articles 200 to 250 of 4607 << Previous Next >>